Genedata ProfilerTM enables translational and clinical researchers to overcome these clinical trial challenges. In a recent I-O clinical trial, scientists using Genedata Profiler followed the process illustrated in Figure. 1 and detailed in this case study to analyze data from 45 patients, and identified predictive biomarkers by integrating genomic, transcriptomic, and metabolomic data, and immunohistochemistry (IHC) tumor profiles. The biomarkers enable further definition of tumor subtypes and thus identification and selection of patient profiles that will benefit from the I-O therapy, consequently improving the outcome of the treatment. Case Study IMMUNO-ONCOLOGY Figure 1: I-O biomarker identification workflow in Genedata Profiler. Recent advances in cancer immunoth

Join for free to read